César Bugallo-Carrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
César Bugallo-Carrera has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Manuel Gandoy-Crego
Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, Faculty of Nursing, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
3 shared publications - Carlos Dosil-Díaz
Department of Developmental Psychology, University of Santiago de Compostela, Santiago de Compostela, Spain
2 shared publications - Iván Otero-González
AtlanTTic, University of Vigo, 36310 Vigo, Spain
2 shared publications - Luis Anido-Rifón
AtlanTTic Research Center, School of Telecommunications Engineering, University of Vigo, 36310 Vigo, Spain
2 shared publications - Manuel Jose Fernández Iglesias
AtlanTTic, University of Vigo, 36310 Vigo, Spain
2 shared publications - Moisés Pacheco-Lorenzo
AtlanTTIC, University of Vigo
2 shared publications
Latest Publications
- Open Access
- 11 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (12) , 5073
Comparative Analysis of MoCA and DigiMoCA Test Results: A Pilot Study
This study examined the cognitive performance of older adults aged 60 and above using the Montreal Cognitive Assessment (MoCA) test and DigiMoCA, a digital tool for cognitive screening administered by means of a smart speaker, to investigate whether the additional variables utilised by DigiMoCA allow for the identification of significant differences between individuals with depressive symptoms and those with mild cognitive impairment, which are not detected using the original MoCA test. A total of 73 senior adults located in Northwestern Spain, 22 male and 51 female, participated in this study. Subjects were divided into four groups based on the presence of depressive symptoms and mild cognitive impairment, with the aim of analysing the results of each dimension of the MoCA and DigiMoCA tests and assessing the additional insights provided by the digital administration tool. The results indicate significant differences among groups. Individuals with depressive symptoms exhibited poorer performance in forward number span, attention, and clock drawing compared to healthy controls. Furthermore, individuals with depressive symptoms and mild cognitive impairment exhibited significantly worse memory and orientation compared to those with cognitive impairment alone. Correlations revealed that a greater severity of depressive symptoms was associated with poorer performance across cognitive domains, including visuospatial skills, attention, language, memory, and phonemic verbal fluency. This study also illustrated how the exploitation of additional variables systematically captured by digital instruments, such as completion times or response delays to individual interactions, may facilitate the early identification of cognitive and depressive conditions, providing initial evidence about the importance of integrating advanced digital tools in cognitive assessment to inspire the development of more effective, personalised interventions.
- 11 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (12) , 5073
Open AccessComparative Analysis of MoCA and DigiMoCA Test Results: A Pilot Study
This study examined the cognitive performance of older adults aged 60 and above using the Montreal Cognitive Assessment (MoCA) test and DigiMoCA, a digital tool for cognitive screening administered by means of a smart speaker, to investigate whether the additional variables utilised by DigiMoCA allow for the identification of significant differences between individuals with depressive symptoms and those with mild cognitive impairment, which are not detected using the original MoCA test. A total of 73 senior adults located in Northwestern Spain, 22 male and 51 female, participated in this study. Subjects were divided into four groups based on the presence of depressive symptoms and mild cognitive impairment, with the aim of analysing the results of each dimension of the MoCA and DigiMoCA tests and assessing the additional insights provided by the digital administration tool. The results indicate significant differences among groups. Individuals with depressive symptoms exhibited poorer performance in forward number span, attention, and clock drawing compared to healthy controls. Furthermore, individuals with depressive symptoms and mild cognitive impairment exhibited significantly worse memory and orientation compared to those with cognitive impairment alone. Correlations revealed that a greater severity of depressive symptoms was associated with poorer performance across cognitive domains, including visuospatial skills, attention, language, memory, and phonemic verbal fluency. This study also illustrated how the exploitation of additional variables systematically captured by digital instruments, such as completion times or response delays to individual interactions, may facilitate the early identification of cognitive and depressive conditions, providing initial evidence about the importance of integrating advanced digital tools in cognitive assessment to inspire the development of more effective, personalised interventions.
- Open Access
- 6 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (11) , 4930
Examining Memory Performance in Senior Adults: A Comparative Cross-Sectional Study
This study investigates memory performance among 73 adults over 60 years old, utilising Memory Impairment Screening (MIS) and self-reported memory failures assessed by the Memory Failures in Everyday questionnaire (MFE-28). Participants were divided into four groups: individuals with depressive symptoms, healthy individuals, individuals with depressive symptoms and mild cognitive impairment, and individuals with mild cognitive impairment only. Groups were organised according to their Montreal Cognitive Assessment (MoCA) and the 15-item Geriatric Depression Scale (GDS-15) scores. The study aims to analyse MIS scores and self-reported memory failures across these groups as measured with the 28-item Memory Failures Everyday (MFE-28) scale. Correlation analyses were conducted for the complete sample, while variance analyses were carried out for the four classification groups above. Bivariate linear regression analysis was carried out to explore how the combination of cognitive and depressive symptoms status influenced memory performance. Results show that subjective memory complaints and memory performance are related to depressive symptoms, and the latter is associated with worse cognitive performance. Lastly, our study highlights that individuals with mild cognitive impairment and depressive symptoms exhibit worse performance in recall tasks and report more subjective memory complaints compared to those with mild cognitive impairment alone.
- 6 June 2024
- Published by MDPI AG in Applied Sciences
- Vol. 14 (11) , 4930
Open AccessExamining Memory Performance in Senior Adults: A Comparative Cross-Sectional Study
This study investigates memory performance among 73 adults over 60 years old, utilising Memory Impairment Screening (MIS) and self-reported memory failures assessed by the Memory Failures in Everyday questionnaire (MFE-28). Participants were divided into four groups: individuals with depressive symptoms, healthy individuals, individuals with depressive symptoms and mild cognitive impairment, and individuals with mild cognitive impairment only. Groups were organised according to their Montreal Cognitive Assessment (MoCA) and the 15-item Geriatric Depression Scale (GDS-15) scores. The study aims to analyse MIS scores and self-reported memory failures across these groups as measured with the 28-item Memory Failures Everyday (MFE-28) scale. Correlation analyses were conducted for the complete sample, while variance analyses were carried out for the four classification groups above. Bivariate linear regression analysis was carried out to explore how the combination of cognitive and depressive symptoms status influenced memory performance. Results show that subjective memory complaints and memory performance are related to depressive symptoms, and the latter is associated with worse cognitive performance. Lastly, our study highlights that individuals with mild cognitive impairment and depressive symptoms exhibit worse performance in recall tasks and report more subjective memory complaints compared to those with mild cognitive impairment alone.
- Open Access
- 26 April 2024
- Published by Edicions de la Universitat de Barcelona in Anuario de Psicología/the Ub Journal of Psychology
- Vol. 54 (1) , 10-18
Equivalencia de las formas alternativas del ‘Montreal Cognitive Assessment’ (MoCA) en el cribado del deterioro cognitivo en adultos mayores
Antecedentes: La detección a través de tests cognitivos breves suele ser el procedimiento de elección preferente para determinar la presencia de deterioro cognitivo objetivo. Entre los instrumentos breves de uso más frecuente está el ‘Montreal Cognitive Assessment’ (MoCA). Elaborado específicamente para la identificación del Deterioro Cognitivo Ligero (DCL) en adultos mayores, dispone de tres versiones que permiten reducir las probabilidades de contaminar las evaluaciones repetidas con el efecto de la práctica. Nos proponemos realizar una revisión sistemática dirigida explorar las características psicométricas de las formas alternativas de las versiones del MoCA y analizar su equivalencia. Método: se realizó una búsqueda en las bases de datos Web of Science, Medline y PsycINFO siguiendo las directrices de la guía PRISMA para revisiones sistemáticas y metaanálisis. La calidad de los artículos fue evaluada utilizando adaptación de la guía COSMIN. Resultados: se seleccionaron ocho artículos que incluyen información psicométrica de al menos dos versiones del instrumento. Conclusiones: Los estudios sobre la equivalencia de las versiones del MoCA son escasos y diversos lo que dificulta sacar conclusiones válidas. Los datos disponibles sugieren que en la versión original se incluyen ítems más difíciles y puntúa más bajo, especialmente al compararla con la versión 7.3 del instrumento.
- 26 April 2024
- Published by Edicions de la Universitat de Barcelona in Anuario de Psicología/the Ub Journal of Psychology
- Vol. 54 (1) , 10-18
Open AccessEquivalencia de las formas alternativas del ‘Montreal Cognitive Assessment’ (MoCA) en el cribado del deterioro cognitivo en adultos mayores
Antecedentes: La detección a través de tests cognitivos breves suele ser el procedimiento de elección preferente para determinar la presencia de deterioro cognitivo objetivo. Entre los instrumentos breves de uso más frecuente está el ‘Montreal Cognitive Assessment’ (MoCA). Elaborado específicamente para la identificación del Deterioro Cognitivo Ligero (DCL) en adultos mayores, dispone de tres versiones que permiten reducir las probabilidades de contaminar las evaluaciones repetidas con el efecto de la práctica. Nos proponemos realizar una revisión sistemática dirigida explorar las características psicométricas de las formas alternativas de las versiones del MoCA y analizar su equivalencia. Método: se realizó una búsqueda en las bases de datos Web of Science, Medline y PsycINFO siguiendo las directrices de la guía PRISMA para revisiones sistemáticas y metaanálisis. La calidad de los artículos fue evaluada utilizando adaptación de la guía COSMIN. Resultados: se seleccionaron ocho artículos que incluyen información psicométrica de al menos dos versiones del instrumento. Conclusiones: Los estudios sobre la equivalencia de las versiones del MoCA son escasos y diversos lo que dificulta sacar conclusiones válidas. Los datos disponibles sugieren que en la versión original se incluyen ítems más difíciles y puntúa más bajo, especialmente al compararla con la versión 7.3 del instrumento.
- Open Access
- 16 December 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (12) , 1721
Neuropsychiatric Symptoms after Liver Transplantation in a 65-Year-Old Male Patient
The development of immunosuppressants has been key for the advancement of solid organ transplant surgery. Specifically, cyclosporine, tacrolimus, or everolimus have significantly increased the survival rate of patients by reducing the risk of a rejection of the transplanted organ and limiting graft-versus-host disease. We report the case of a 65-year-old man who, after undergoing a liver transplantation and receiving an immunosuppressive treatment with cyclosporine and everolimus, presented severe obsessive, psychotic, and behavioral symptoms over the past three years, and describe the pharmacological and non-pharmacological interventions implemented against these symptoms. In this case, the immunosuppressants used have been cyclosporine and, preferably, everolimus. On the other hand, potential adverse reactions to the treatment have been observed, including neuropsychiatric symptoms such as tremor, anxiety, dysthymia, psychosis, and behavioral disorders, which make it necessary to use corrective psychoactive drugs such as benzodiazepines, antidepressants, and antipsychotics, combined with non-pharmacological interventions. A transversal approach, from the medical and psychosocial disciplines, facilitates success in managing neuropsychiatric symptoms after soft organ transplants.
- 16 December 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (12) , 1721
Open AccessNeuropsychiatric Symptoms after Liver Transplantation in a 65-Year-Old Male Patient
The development of immunosuppressants has been key for the advancement of solid organ transplant surgery. Specifically, cyclosporine, tacrolimus, or everolimus have significantly increased the survival rate of patients by reducing the risk of a rejection of the transplanted organ and limiting graft-versus-host disease. We report the case of a 65-year-old man who, after undergoing a liver transplantation and receiving an immunosuppressive treatment with cyclosporine and everolimus, presented severe obsessive, psychotic, and behavioral symptoms over the past three years, and describe the pharmacological and non-pharmacological interventions implemented against these symptoms. In this case, the immunosuppressants used have been cyclosporine and, preferably, everolimus. On the other hand, potential adverse reactions to the treatment have been observed, including neuropsychiatric symptoms such as tremor, anxiety, dysthymia, psychosis, and behavioral disorders, which make it necessary to use corrective psychoactive drugs such as benzodiazepines, antidepressants, and antipsychotics, combined with non-pharmacological interventions. A transversal approach, from the medical and psychosocial disciplines, facilitates success in managing neuropsychiatric symptoms after soft organ transplants.